Vanda Pharmaceuticals (VNDA) Free Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.87% |
| Dec 31, 2025 | 7.13% |
| Sep 30, 2025 | -104.40% |
| Jun 30, 2025 | 53.69% |
| Mar 31, 2025 | -1,553.52% |
| Dec 31, 2024 | 86.22% |
| Sep 30, 2024 | -109.52% |
| Jun 30, 2024 | -193.04% |
| Mar 31, 2024 | 289.76% |
| Dec 31, 2023 | -92.14% |
| Sep 30, 2023 | 84.38% |
| Jun 30, 2023 | -141.81% |
| Mar 31, 2023 | 246.90% |
| Dec 31, 2022 | -27.87% |
| Sep 30, 2022 | 131.05% |
| Jun 30, 2022 | 38.30% |
| Mar 31, 2022 | -85.00% |
| Dec 31, 2021 | 181.42% |
| Sep 30, 2021 | -49.75% |
| Jun 30, 2021 | 106.54% |
| Mar 31, 2021 | -50.57% |
| Dec 31, 2020 | 100.88% |
| Sep 30, 2020 | -61.64% |
| Jun 30, 2020 | 1,959.06% |
| Mar 31, 2020 | -113.16% |
| Dec 31, 2019 | 70.46% |
| Sep 30, 2019 | -71.83% |
| Jun 30, 2019 | 118.93% |
| Mar 31, 2019 | -39.31% |
| Dec 31, 2018 | 78.09% |
| Sep 30, 2018 | 98.29% |
| Jun 30, 2018 | 187.16% |
| Mar 31, 2018 | -54.11% |
| Dec 31, 2017 | 82.25% |
| Sep 30, 2017 | 162.31% |
| Jun 30, 2017 | 50.57% |
| Mar 31, 2017 | -210.37% |
| Dec 31, 2016 | -392.83% |
| Sep 30, 2016 | 119.68% |
| Jun 30, 2016 | 33.41% |
| Mar 31, 2016 | -357.85% |
| Dec 31, 2015 | 81.31% |
| Sep 30, 2015 | -147.93% |
| Jun 30, 2015 | 150.31% |
| Mar 31, 2015 | 134.77% |
| Dec 31, 2014 | -79.35% |
| Sep 30, 2014 | 79.27% |
| Jun 30, 2014 | -53.53% |
| Mar 31, 2014 | -96.24% |
| Dec 31, 2013 | -19.19% |
| Sep 30, 2013 | -27.01% |
| Jun 30, 2013 | 11.54% |
| Mar 31, 2013 | 33.98% |
| Dec 31, 2012 | -36.10% |
| Sep 30, 2012 | 17.64% |
| Jun 30, 2012 | -17.34% |
| Mar 31, 2012 | 15.27% |
| Dec 31, 2011 | -72.60% |
| Sep 30, 2011 | -28.21% |
| Jun 30, 2011 | -72.15% |
| Mar 31, 2011 | 35.95% |
| Dec 31, 2010 | -0.43% |